Interestingly, there was a noticeable reduction in tdTOM+ tumor migration along the corpus callosum to the contralateral hemisphere, even at terminal stages, although OLIG2 was still present in these tumors (Fig. 2h, i). The gene discussed is OLIG2; the disease is neoplasm.